首页 > 市场调查报告书 > 食物/饮料

食品添加剂

市场调查报告书

商品编码

1418684

全球脂肪酶市场 - 2023-2030

Global Lipase Market - 2023-2030

出版日期: 2024年01月23日 | 出版商:

DataM Intelligence | 英文 186 Pages | 商品交期: 最快1-2个工作天内

价格

※ 本网页内容可能与最新版本有所差异。详细情况请与我们联繫。

简介目录

概述

2022年全球脂肪酶市场规模达7.2912亿美元，预计2030年将达到1,2094.1亿美元，2023-2030年预测期间CAGR为6.53%。

人们对健康和保健意识的不断增强正在推动对特定膳食脂肪酶产品的需求。脂肪酶用于生产低脂肪和低胆固醇食品。随着越来越多的消费者寻求更健康的食品选择，这一趋势预计将继续对脂肪酶市场产生积极影响。清洁标籤和植物性食品运动正在影响脂肪酶市场，促使製造商寻求符合这些趋势的酵素。

欧洲对含有天然成分的清洁标籤产品的需求正在激增。这一趋势正在推动脂肪酶在食品和饮料製造中作为清洁标籤酶的使用。製造商正在从非基因改造生物（non-GMO）和其他天然来源中寻找脂肪酶，以满足消费者的喜好，扩大市场。

例如，2022年11月8日，帝斯曼推出了四项创新解决方案，旨在最大限度地提高原材料的性能。其中一项创新 Panamore Xtense 是在 FiE 上推出的。这种标籤友善脂肪酶可作为常用乳化剂 DATEM 的可持续替代品。它透过增强麵团稳定性并优化体积和形状，为麵包生产商提供了显着的优势。

动力学

对加工食品不断增长的需求

加工食品消费量的增加刺激了食品加工各阶段对脂肪酶等酵素的需求。脂肪酶在将脂肪分解为脂肪酸和甘油方面发挥着重要作用，使其在食品製造中不可或缺。脂肪酶帮助食品公司增强加工食品的风味。这导致零食和即食食品的生产品质得到改善，对消费者更具吸引力。

脂肪酶正在为延长保质期食品的开发做出贡献。透过分解脂肪，它有助于减少酸败并延长加工食品的寿命，解决製造商和消费者的关键问题。食品业正在见证多样化加工食品的发展激增，推动市场成长。

健康意识不断增强的消费者

注重健康的消费者正在积极寻找更健康的食品选择。这一趋势推动了低脂肪和低热量食品生产中对脂肪酶的需求，与注重更好营养和体重管理的饮食偏好相一致。脂肪酶用于降低加工食品的脂肪含量而不影响味道。注重健康的人喜欢脂肪含量较低的食品，这是推动市场成长的因素。

根据胰臟癌行动网报道，2022 年 7 月 5 日，美国食品药物管理局 (FDA) 建议个人在食用零食时开始服用 10,000 - 20,000 个脂肪酶单位，随餐服用 20,000 - 40,000 个脂肪酶单位。假设每天总共四餐，患者必须遵守每餐每公斤体重不超过 2,500 脂肪酶单位的指导方针。

生产成本高

脂肪酶製造过程中的高生产成本导致市场上营运的公司的利润率下降。这种有限的获利能力阻碍了市场成长，因为它限制了可用于研发、行销和扩张的资源。高生产成本通常会导致脂肪酶产品价格上涨，从而限制市场成长。

高生产成本的负担对于在脂肪酶市场运营的中小型企业（SME）来说尤其具有挑战性。这些公司在保持有竞争力的定价方面面临困难，这限制了它们的市场成长潜力。高生产成本为希望投资脂肪酶市场的新进业者和新创公司设置了障碍。

Overview

Global Lipase Market reached US$ 729.12 million in 2022 and is expected to reach US$ 1209.41 billion by 2030, growing with a CAGR of 6.53% during the forecast period 2023-2030.

Growing awareness of health and wellness is driving the demand for specific dietary lipase products. Lipases are used in the production of low-fat and low-cholesterol food items. As more consumers seek healthier food choices, this trend is expected to continue influencing the lipase market positively. The clean-label and plant-based food movements are influencing the lipase market, prompting manufacturers to seek enzymes that align with these trends.

Europe is experiencing a surge in demand for clean-label products with natural ingredients. This trend is propelling the utilization of lipases as clean-label enzymes in food and beverage manufacturing. Manufacturers are seeking lipases from non-genetically modified organisms (non-GMO) and other natural sources to meet consumer preferences, expanding the market.

For instance, on November 8, 2022, DSM introduced four innovative solutions aimed at maximizing the performance of raw materials. One of these innovations, Panamore Xtense, was launched at FiE. This label-friendly lipase serves as a sustainable substitute for the commonly used emulsifier DATEM. It offers significant advantages to bread producers by enhancing dough stability and optimizing volume and shape.

Dynamics

Growing Demand for Processed Food

The rising consumption of processed foods is stimulating the need for enzymes like lipase in various stages of food processing. Lipase plays a role in breaking down fats into fatty acids and glycerol, making it indispensable in food manufacturing. Lipase helps food companies enhance the flavor profiles of processed foods. This is leading to the production of snacks and ready-to-eat meals with improved taste, making them more appealing to consumers.

Lipase is contributing to the development of food products with extended shelf life. By breaking down fats, it helps reduce rancidity and improves the longevity of processed food items, addressing a critical concern for both manufacturers and consumers. The food industry is witnessing a surge in the development of diverse processed food products, driving market growth.

Rising Health-Conscious Consumers

Health-conscious consumers are actively seeking out healthier food options. This trend drives the demand for lipase in the production of low-fat and low-calorie food products, aligning with dietary preferences are focusing on better nutrition and weight management. Lipase enzymes are used to reduce the fat content of processed foods without compromising taste. Health-conscious individuals prefer food items with lower fat content, which are factors driving market growth.

According to the Pancreatic Cancer Action Network, on July 5, 2022, the United States Food and Drug Administration (FDA) recommends that individuals begin with a dosage of 10,000 - 20,000 lipase units when consuming snacks and 20,000 - 40,000 lipase units with meals. Patients must adhere to the guideline of not surpassing 2,500 lipase units per kilogram of body weight per meal, assuming a total of four meals per day.

High Production Costs

High production costs in the lipase manufacturing process are leading to reduced profit margins for companies operating in the market. This limited profitability is hindering market growth, as it is constraining resources available for research and development, marketing, and expansion. High production costs often translate into higher prices for lipase-based products, restraining market growth.

The burden of high production costs is particularly challenging for small and medium-sized enterprises (SMEs) operating in the lipase market. These companies are facing difficulties in maintaining competitive pricing, which limits their market growth potential. High production costs are creating barriers for new entrants and startups looking to invest in the lipase market.

Segment Analysis

The global lipase market is segmented based on source, form, application, and region.

Growing Availability, Cost-Effectiveness, and Versatility of Microbial Lipase

The microbial segment held the largest share of the global lipase market. Microbial lipases are derived from microorganisms like bacteria and fungi. It is produced on a large scale, and this widespread availability ensures a stable supply for the market. Microbial lipases are a cost-effective choice for many industries. Their efficient production costs make them an attractive option for various applications.

Microbial lipases display versatility in their catalytic activities, making them suitable for a wide range of applications. This adaptability allows them to serve multiple sectors, such as food and biofuels. Manufacturers and researchers are focusing on enhancing the properties of microbial lipases to meet specific industrial needs. These tailored solutions cater to the diverse requirements of different applications.

Geographical Penetration

Robust Industrial Presence, Diverse Applications in Europe

Europe held the dominant position in the global lipase market. Europe has a strong, well-established food sector in countries such as Germany, France, and Italy, which is contributing significantly to the growth of the lipase market in the region. Europe is maintaining stringent quality and safety standards for the production and application of lipases in various sectors. This commitment to quality and compliance is enhancing the trust of consumers and industries in lipase products.

Lipase enzymes find applications in a wide range of sectors, from the food and pharmaceutical industries to biotechnology. The diversity of applications is allowing Europe to cater to a broad customer base. European companies are continually introducing innovative lipase products tailored to specific industry needs. This product innovation is helping them maintain a strong foothold in the market.

For instance, on May 29, 2020, Biocatalysts Ltd, specialists in enzymes, introduced its latest enzyme, Lipomod 767P. This non-genetically modified microbial lipase preparation is well-suited for both the hydrolysis and esterification of oils and fats. Its wide-ranging pH compatibility allows for use across various substrate types. Lipomod 767P offers the capability to selectively hydrolyze triglycerides, releasing free fatty acids.

COVID-19 Impact Analysis:

The global lipase market faced supply chain disruptions due to lockdowns, restrictions, and transportation challenges, which have affected the timely availability of lipase products in the market. Lipase has applications in various end-user industries, including food, pharmaceuticals, and research. The disruptions in these sectors negatively affected the overall market as businesses scaled back production and research activities.

However, the lipase market experienced growth in the pharmaceutical sector as lipase enzymes played a role in potential treatments or vaccines for COVID-19. This led to increased research and development activities in the pharmaceutical market segment. The pandemic accelerated the adoption of e-commerce and home cooking. As a result, there was increased demand for lipase in consumer-friendly formats for baking and cooking, which benefited the market.

Russia-Ukraine War Impact Analysis

The lipase market has relied on a steady supply of raw materials. The geopolitical tension between Russia and Ukraine led to uncertainties in the sourcing of essential raw materials, which negatively impacted production. The lipase market experienced supply chain disruptions as the conflict disrupted transportation routes and logistics networks. This hampered the timely delivery of lipase products to various regions.

The conflict prompted greater emphasis on sustainability and self-sufficiency in various industries. This shift towards sustainability has driven innovation and growth in the lipase market as consumers and industries have sought more sustainable products. In response to the geopolitical tensions, players in the lipase market explored diversifying their supply sources to mitigate risks associated with dependency on specific regions.

By Source

Microbial
Animal
Plant

By Form

Liquid
Powder

By Application

Dairy
Bakery and Confectionery
Animal Feed
Others

By Region

North America
- U.S.
- Canada
- Mexico
Europe
- Germany
- UK
- France
- Italy
- Russia
- Rest of Europe
South America
- Brazil
- Argentina
- Rest of South America
Asia-Pacific
- China
- India
- Japan
- Australia
- Rest of Asia-Pacific
Middle East and Africa

Key Developments

On August 31, 2023, Alcresta Therapeutics, Inc., a prominent company specializing in the development and commercialization of innovative enzyme-based products, announced that the U.S. Food and Drug Administration (FDA) has granted clearance for the extended use of RELiZORB in children aged 2 to under 5 years. RELiZORB is a digestive enzyme cartridge designed to replicate the function of pancreatic lipase.
On February 25, 2020, Researchers from the University of Portsmouth, in collaboration with an international team, created an enzyme derived from agricultural waste. This enzyme, produced from a by-product of mustard seeds, has the potential to become a valuable additive in laundry detergents. The aim is to develop an economical, naturally sourced alternative to lipase, the second most widely produced enzyme on the market.
On December 18, 2023, Zomedica Corp. introduced three new assays - Canine Pancreatic Lipase (cPL), Cobalamin (B12), and Folate - for the TRUFORMA In-Clinic Biosensor Testing Platform.

Competitive Landscape

The major global players in the lipase market include: Koninklijke DSM N.V., Novozymes A/S, Clerici-Sacco Group, Renco New Zealand, Enzyme Development Corporation, Chr. Hansen Holdings A/S, Amano Enzymes Inc., Associated British Foods PLC, International Flavors & Fragrances Inc., and Advanced Enzyme Tech.

Why Purchase the Report?

To visualize the global lipase market segmentation based on source, form, application, and region, as well as understand critical commercial assets and players.
Identify commercial opportunities by analyzing trends and co-development.
Excel data sheet with numerous lipase market-level data points with all segments.
PDF report consists of a comprehensive analysis after exhaustive qualitative interviews and an in-depth study.
Product mapping available as excel consisting of critical products of all the major players.

The global lipase market report would provide approximately 61 tables, 57 figures, and 186 Pages.

Target Audience 2023

Manufacturers/ Buyers
Industry Investors/Investment Bankers
Research Professionals
Emerging Companies

1. Methodology and Scope

1.1. Research Methodology
1.2. Research Objective and Scope of the Report

2. Definition and Overview

3. Executive Summary

3.1. Snippet by Source
3.2. Snippet by Form
3.3. Snippet by Application
3.4. Snippet by Region

4. Dynamics

4.1. Impacting Factors
- 4.1.1. Drivers
  - 4.1.1.1. Growing Demand for Processed Food
  - 4.1.1.2. Rising Health-Conscious Consumers
- 4.1.2. Restraints
  - 4.1.2.1. High Production Costs
- 4.1.3. Opportunity
- 4.1.4. Impact Analysis

5. Industry Analysis

5.1. Porter's Five Force Analysis
5.2. Supply Chain Analysis
5.3. Pricing Analysis
5.4. Regulatory Analysis
5.5. Russia-Ukraine War Impact Analysis
5.6. DMI Opinion

6. COVID-19 Analysis

6.1. Analysis of COVID-19
- 6.1.1. Scenario Before COVID
- 6.1.2. Scenario During COVID
- 6.1.3. Scenario Post COVID
6.2. Pricing Dynamics Amid COVID-19
6.3. Demand-Supply Spectrum
6.4. Government Initiatives Related to the Market During Pandemic
6.5. Manufacturers Strategic Initiatives
6.6. Conclusion

7. By Source

7.1. Introduction
- 7.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Source
- 7.1.2. Market Attractiveness Index, By Source
7.2. Microbial*
- 7.2.1. Introduction
- 7.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
7.3. Animal
7.4. Plant

8. By Form

8.1. Introduction
- 8.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Form
- 8.1.2. Market Attractiveness Index, By Form
8.2. Liquid*
- 8.2.1. Introduction
- 8.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
8.3. Powder

9. By Application

9.1. Introduction
- 9.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
- 9.1.2. Market Attractiveness Index, By Application
9.2. Dairy*
- 9.2.1. Introduction
- 9.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
9.3. Bakery and Confectionery
9.4. Animal Feed
9.5. Others

10. By Region

10.1. Introduction
- 10.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Region
- 10.1.2. Market Attractiveness Index, By Region
10.2. North America
- 10.2.1. Introduction
- 10.2.2. Key Region-Specific Dynamics
- 10.2.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Source
- 10.2.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Form
- 10.2.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
- 10.2.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
  - 10.2.6.1. U.S.
  - 10.2.6.2. Canada
  - 10.2.6.3. Mexico
10.3. Europe
- 10.3.1. Introduction
- 10.3.2. Key Region-Specific Dynamics
- 10.3.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Source
- 10.3.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Form
- 10.3.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
- 10.3.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
  - 10.3.6.1. Germany
  - 10.3.6.2. UK
  - 10.3.6.3. France
  - 10.3.6.4. Italy
  - 10.3.6.5. Russia
  - 10.3.6.6. Rest of Europe
10.4. South America
- 10.4.1. Introduction
- 10.4.2. Key Region-Specific Dynamics
- 10.4.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Source
- 10.4.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Form
- 10.4.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
- 10.4.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
  - 10.4.6.1. Brazil
  - 10.4.6.2. Argentina
  - 10.4.6.3. Rest of South America
10.5. Asia-Pacific
- 10.5.1. Introduction
- 10.5.2. Key Region-Specific Dynamics
- 10.5.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Source
- 10.5.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Form
- 10.5.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
- 10.5.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
  - 10.5.6.1. China
  - 10.5.6.2. India
  - 10.5.6.3. Japan
  - 10.5.6.4. Australia
  - 10.5.6.5. Rest of Asia-Pacific
10.6. Middle East and Africa
- 10.6.1. Introduction
- 10.6.2. Key Region-Specific Dynamics
- 10.6.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Source
- 10.6.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Form
- 10.6.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application

11. Competitive Landscape

11.1. Competitive Scenario
11.2. Market Positioning/Share Analysis
11.3. Mergers and Acquisitions Analysis

12. Company Profiles

12.1. Koninklijke DSM N.V*
- 12.1.1. Company Overview
- 12.1.2. Product Portfolio and Description
- 12.1.3. Financial Overview
- 12.1.4. Key Developments
12.2. Novozymes A/S
12.3. Clerici-Sacco Group
12.4. Renco New Zealand
12.5. Enzyme Development Corporation
12.6. Chr. Hansen Holdings A/S
12.7. Amano Enzymes Inc.
12.8. Associated British Foods PLC
12.9. International Flavors & Fragrances Inc.
12.10. Advanced Enzyme Tech

LIST NOT EXHAUSTIVE.

13. Appendix

13.1. About Us and Services
13.2. Contact Us

02-2729-4219

+886-2-2729-4219

License/价格